Saratoga Investment
Open
$23.28
Prev. Close
$23.28
High
$23.28
Low
$23.19
Market Snapshot
$365.08M
9.5
2.51
$154.79M
Saratoga Investment Corp is a US-based company operating in Capital Markets industry. The company is headquartered in New York City, New York and currently employs 0 full-time employees. The company went IPO on 2010-08-13. Saratoga Investment Corp. is a specialty finance company that provides customized financing solutions to United States middle-market businesses. The firm invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its investment’s objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments. The Company’s portfolio is comprised primarily of investments in leveraged loans issued by middle-market companies. The company also invests in mezzanine debt and makes equity investments in middle-market companies. The Company’s investment activities are externally managed and advised by Saratoga Investment Advisors, LLC.
emptyResult
Saratoga Investment Corp is a US-based company operating in Capital Markets industry. The company is headquartered in New York City, New York and currently employs 0 full-time employees. The company went IPO on 2010-08-13. Saratoga Investment Corp. is a specialty finance company that provides customized financing solutions to United States middle-market businesses. The firm invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its investment’s objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments. The Company’s portfolio is comprised primarily of investments in leveraged loans issued by middle-market companies. The company also invests in mezzanine debt and makes equity investments in middle-market companies. The Company’s investment activities are externally managed and advised by Saratoga Investment Advisors, LLC.
Recently from Cashu
Hua Medicine Launches MYHOMSIS® for Diabetes, Pioneering Treatment in Hong Kong
Hua Medicine Launches Groundbreaking Diabetes Treatment in Hong Kong Hua Medicine, a prominent player in the pharmaceutical landscape, celebrates a milestone with the approval of its first-in-class gl…
Hua Medicine Launches Glucokinase Activator MYHOMSIS® for Type 2 Diabetes in Hong Kong
Hua Medicine's Game-Changing Glucokinase Activator Launches in Hong Kong Hua Medicine achieves a pivotal milestone with the recent approval of dorzagliatin, branded as MYHOMSIS®, for marketing in Hong…
Hua Medicine’s MYHOMSIS® Approval: Transforming Diabetes Treatment in Hong Kong and Beyond
Hua Medicine's Groundbreaking Approval for MYHOMSIS® Marks a New Era for Diabetes Treatment Hua Medicine receives significant recognition with the recent approval of its innovative glucokinase activat…
Haims Capital Launches RKM 6.0 to Enhance Investment Decision-Making Amid Market Volatility
Haims Capital Unveils RKM 6.0 to Navigate Market Volatility Haims Capital, a financial technology firm recognized for its innovative investment analytics, announces the impending launch of RKM 6.0, an…